Do Patients With Stroke, Coronary Artery Disease, or Both Achieve Similar Treatment Goals?
on behalf of the Stroke Outcome Research Canada (SORCan) Working Group From the Canadian Heart Research Centre and Terrence Donnelly Heart Centre, Division of Cardiology, University of Toronto, Canada (R.T.Y., S.G.G., D.H.F., A.L., A.T.Y.); and Division of Endocrinology and Metabolism, St. Michael s Hospital, University of Toronto (L.A.L.); Canadian Heart Research Centre (A.C.), University of Toronto, Canada; Stroke Research Unit, Mobility Program, Division of Neurology, Department of Medicine, St. Michael s Hospital, University of Toronto, Canada (G.S., N.H.B.); and Health Policy Management and Evaluation (HPME), University of Toronto and Institute of Evaluative Clinical Sciences (ICES), Canada (G.S.). Correspondence to Dr Gustavo Saposnik, Stroke Research Unit, St. Michael s Hospital, Division of Neurology, 55 Queen St E, Room 93, Toronto, Ontario, Canada M5C 1R6.
Related Questions
- Do hypertensive post-stroke patients receive and act upon treatment recommendations to reduce recurrent stroke risk?
- Does Antihypertensive Treatment Reduce Stroke Related Mortality and Disability in Patients with Acute ICH?
- In patients with atrial fibrillation (AF), what is the recommended treatment to prevent stroke?
